(Q44636976)

4 December 2017

title

Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism (English)

1 reference

https://api.crossref.org/works/10.1056/NEJMOA035451

4 December 2017

Subcutaneous Fondaparinux versus Intravenous Unfractionated Heparin in the Initial Treatment of Pulmonary Embolism (English)

1 reference

26 March 2024

1 reference

4

A. Gallus

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14585937

26 March 2024

author name string

Matisse Investigators

13

1 reference

4 December 2017

H. R. Büller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14585937

26 March 2024

B. L. Davidson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14585937

26 March 2024

H. Decousus

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14585937

26 March 2024

M. Gent

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14585937

26 March 2024

F. Piovella

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14585937

26 March 2024

M. H. Prins

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14585937

26 March 2024

G. Raskob

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14585937

26 March 2024

A. E M. van den Berg-Segers

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14585937

26 March 2024

R. Cariou

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14585937

26 March 2024

O. Leeuwenkamp

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14585937

26 March 2024

A. W A. Lensing

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14585937

26 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

4 December 2017

30 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14585937

The New England Journal of Medicine

26 March 2024

published in

1 reference

4 December 2017

volume

349

1 reference

4 December 2017

issue

18

1 reference

4 December 2017

page(s)

1695-1702

1 reference

https://api.crossref.org/works/10.1056/NEJMOA035451

4 December 2017

1

1 reference

Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial

26 March 2024

https://api.crossref.org/works/10.1056/NEJMOA035451

2

1 reference

Cochrane Database of Systematic Reviews

26 March 2024

3

2

CD001100

van Den Belt AG

2000

1 reference

https://api.crossref.org/works/10.1056/NEJMOA035451

Antithrombotic therapy for venous thromboembolic disease

26 March 2024

https://api.crossref.org/works/10.1056/NEJMOA035451

4

1 reference

Low-molecular-weight heparin in the treatment of patients with venous thromboembolism

26 March 2024

https://api.crossref.org/works/10.1056/NEJMOA035451

5

1 reference

A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire

26 March 2024

https://api.crossref.org/works/10.1056/NEJMOA035451

6

1 reference

Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease

26 March 2024

https://api.crossref.org/works/10.1056/NEJMOA035451

7

1 reference

The synthetic pentasaccharide fondaparinux: first in the class of antithrombotic agents that selectively inhibit coagulation factor Xa.

26 March 2024

https://api.crossref.org/works/10.1056/NEJMOA035451

8

1 reference

Treatment of proximal deep vein thrombosis with a novel synthetic compound (SR90107A/ORG31540) with pure anti-factor Xa activity: A phase II evaluation. The Rembrandt Investigators

26 March 2024

https://api.crossref.org/works/10.1056/NEJMOA035451

9

1 reference

26 March 2024

Deep-vein thrombosis

https://api.crossref.org/works/10.1056/NEJMOA035451

10

1 reference

Recurrent venous thrombosis and heparin therapy: an evaluation of the importance of early activated partial thromboplastin times.

26 March 2024

https://api.crossref.org/works/10.1056/NEJMOA035451

11

1 reference

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

26 March 2024

https://api.crossref.org/works/10.1056/NEJMOA035451

12

1 reference

A simple ultrasound approach for detection of recurrent proximal-vein thrombosis.

26 March 2024

https://api.crossref.org/works/10.1056/NEJMOA035451

13

1 reference

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

26 March 2024

https://api.crossref.org/works/10.1056/NEJMOA035451

15

1 reference

Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis

26 March 2024

https://api.crossref.org/works/10.1056/NEJMOA035451

16

1 reference

Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis

26 March 2024

https://api.crossref.org/works/10.1056/NEJMOA035451

17

1 reference

Prediction of creatinine clearance from serum creatinine

26 March 2024

https://api.crossref.org/works/10.1056/NEJMOA035451

18

1 reference

Intravenous heparin dosing: patterns and variations in internists' practices

26 March 2024

https://api.crossref.org/works/10.1056/NEJMOA035451

19

1 reference

26 March 2024

Identifiers

DOI

10.1056/NEJMOA035451

1 reference

4 December 2017

1 reference